HALOPERIDOL Safety Questions, HALOPERIDOL Answers
More Here>>Side Effects - FDA Reports 2006-2008
Medications A-Z: A B C D E F G H I J K L M N O P Q R S T U V W X Y ZWelcome! Patientsville.com provides unique information about HALOPERIDOL. Our extensive database of HALOPERIDOL adverse events and HALOPERIDOL warnings is updated regularly. If you have questions, you can post them to one of our health experts or ask others in our broad patient community.
>> Announcements
Check out our Hospital and Home Care Quality Reports.
Ask Our Health Experts about HALOPERIDOL
HALOPERIDOL Safety Reports
Total HALOPERIDOL reports: 122.HALOPERIDOL FDA safety alerts: 2007 .
Reported deaths: 28 Reported hospitalizations: 48.
Take HALOPERIDOL Side Effects Survey or Share Your HALOPERIDOL Story. HALOPERIDOL Usage.
Showing 1-75 of 122 Next >
Pharmacist from UNITED STATES reported HALOPERIDOL problem on Oct 19, 2006. Female patient, 57 years of age, was diagnosed with psychotic disorder and was treated with HALOPERIDOL. After drug was administered, patient experienced the following problems/side effects: drooling, tremor. HALOPERIDOL dosage: HALOPERIDOL 1 MG PO BID. Patient recovered.HALOPERIDOL problem was reported by a Physician from BRAZIL on Oct 15, 2006. Female patient, child 2 years of age, was diagnosed with accidental exposure and was treated with HALOPERIDOL. After drug was administered, patient experienced the following problems/side effects: extrapyramidal disorder. HALOPERIDOL dosage: unknown. Patient was hospitalized. Patient recovered.
Physician from GERMANY reported HALOPERIDOL problem on Oct 16, 2006. Male patient, weighting 149.9 lb, was diagnosed with acute psychosis and was treated with HALOPERIDOL. After drug was administered, patient experienced the following problems/side effects: overdose. HALOPERIDOL dosage: unknown. During the same period patient was treated with HALOPERIDOL DECANOATE. Patient was hospitalized. Patient recovered.
HALOPERIDOL problem was reported by a Consumer or non-health professional from UNITED KINGDOM on Oct 19, 2006. Female patient was treated with HALOPERIDOL. After drug was administered, patient experienced the following problems/side effects: cerebrovascular accident, dysphagia, speech disorder. HALOPERIDOL dosage: unknown. Patient was hospitalized. Patient recovered.
Health Professional from UNITED KINGDOM reported HALOPERIDOL problem on Feb 05, 2004. Male patient, 28 years of age, was diagnosed with schizophrenia and was treated with HALOPERIDOL. After drug was administered, patient experienced the following problems/side effects: aortic arteriosclerosis, cardiac failure, cardiomegaly, circulatory collapse, congestive cardiomyopathy, coronary artery disease, dilatation ventricular, ejection fraction decreased, exercise tolerance decreased. HALOPERIDOL dosage: unknown. During the same period patient was treated with METFORMIN, GLICLAZIDE, SALBUTAMOL INHALANT, CLOZARIL. Patient was hospitalized. Patient died on 06/22/2005.
HALOPERIDOL problem was reported by a Health Professional from UNITED KINGDOM on Feb 05, 2004. Male patient, 28 years of age, was diagnosed with schizophrenia and was treated with HALOPERIDOL. After drug was administered, patient experienced the following problems/side effects: aortic arteriosclerosis, cardiac failure, cardiomegaly, circulatory collapse, congestive cardiomyopathy, coronary artery disease, dilatation ventricular, ejection fraction decreased, exercise tolerance decreased. HALOPERIDOL dosage: unknown. During the same period patient was treated with METFORMIN, GLICLAZIDE, SALBUTAMOL INHALANT, CLOZARIL. Patient was hospitalized. Patient died on 06/22/2005.
Pharmacist from UNITED STATES reported HALOPERIDOL problem on Nov 02, 2006. Male patient, weighting 167.6 lb, was diagnosed with schizophrenia and was treated with HALOPERIDOL. After drug was administered, patient experienced the following problems/side effects: blood creatine phosphokinase increased, constipation, eschar, escherichia urinary tract infection, faecal incontinence, mental status changes, pneumonia, urinary incontinence. HALOPERIDOL dosage: HALOPERIDOL 5MG EVERY SIX HOURS PO. During the same period patient was treated with OLANZAPINE. Patient was hospitalized. Patient recovered.
HALOPERIDOL problem was reported by a Consumer or non-health professional from UNITED STATES on Mar 02, 2006. Male patient, 36 years of age, weighting 198.0 lb, was diagnosed with bipolar i disorder and was treated with HALOPERIDOL. After drug was administered, patient experienced the following problems/side effects: biliary tract disorder, hepatitis viral, pancreatitis. HALOPERIDOL dosage: unknown. During the same period patient was treated with FLUOXETINE HYDROCHLORIDE, ZYPREXA. Patient was hospitalized. Patient recovered.
Physician from SPAIN reported HALOPERIDOL problem on Oct 04, 2006. Male patient, 71 years of age, was diagnosed with hallucination, visual, cognitive disorder and was treated with HALOPERIDOL. After drug was administered, patient experienced the following problems/side effects: bradyphrenia, depressed level of consciousness, dysphagia, parkinsonism. HALOPERIDOL dosage: unknown. Patient recovered.
HALOPERIDOL problem was reported by a Physician from NETHERLANDS on Oct 28, 2006. Male patient, 45 years of age, was diagnosed with schizophrenia, paranoid type and was treated with HALOPERIDOL. After drug was administered, patient experienced the following problems/side effects: inappropriate antidiuretic hormone secretion. HALOPERIDOL dosage: unknown. During the same period patient was treated with QUETIAPINE FUMARATE. Patient recovered.
Pharmacist from UNITED STATES reported HALOPERIDOL problem on Nov 16, 2006. Male patient, 81 years of age, weighting 165.0 lb, was diagnosed with delirium and was treated with HALOPERIDOL. After drug was administered, patient experienced the following problems/side effects: agitation, cardiac arrest, delirium, dementia, torsade de pointes, ventricular fibrillation. HALOPERIDOL dosage: unknown. Patient recovered.
HALOPERIDOL problem was reported by a Pharmacist from UNITED STATES on Nov 20, 2006. Male patient, 38 years of age, weighting 200.0 lb, was treated with HALOPERIDOL. After drug was administered, patient experienced the following problems/side effects: akathisia, extrapyramidal disorder, tremor. HALOPERIDOL dosage: 100MG Q4WEEKS IM. Patient recovered.
Physician from UNITED STATES reported HALOPERIDOL problem on Oct 24, 2006. Female patient, 52 years of age, was treated with HALOPERIDOL. After drug was administered, patient experienced the following problems/side effects: completed suicide. HALOPERIDOL dosage: unknown. During the same period patient was treated with NORTRIPTYLINE, OXCARBAZEPINE. Patient died.
HALOPERIDOL problem was reported by a Physician from UNITED STATES on Oct 24, 2006. Male patient, 20 years of age, was treated with HALOPERIDOL. After drug was administered, patient experienced the following problems/side effects: cardio-respiratory arrest, completed suicide, heart rate increased, refusal of treatment by patient. HALOPERIDOL dosage: unknown. During the same period patient was treated with NORTRIPTYLINE, ASPIRIN. Patient died.
Physician from UNITED STATES reported HALOPERIDOL problem on Oct 24, 2006. Female patient, 29 years of age, was treated with HALOPERIDOL. After drug was administered, patient experienced the following problems/side effects: cardiac arrest, respiratory arrest. HALOPERIDOL dosage: unknown. During the same period patient was treated with AMITRIPTYLINE, ZIPRASIDONE. Patient died.
HALOPERIDOL problem was reported by a Health Professional from UNITED KINGDOM on Nov 13, 2006. Female patient, 68 years of age, weighting 121.3 lb, was diagnosed with anxiety, agitation, depression and was treated with HALOPERIDOL. After drug was administered, patient experienced the following problems/side effects: akathisia. HALOPERIDOL dosage: unknown. During the same period patient was treated with LITHIUM CARBONATE, LOFEPRAMINE, MIRTAZAPINE, TRAZODONE. Patient recovered.
Health Professional from ROMANIA reported HALOPERIDOL problem on Nov 16, 2006. Male patient, weighting 163.1 lb, was diagnosed with psychotic disorder, agitation and was treated with HALOPERIDOL. After drug was administered, patient experienced the following problems/side effects: schizophrenia, paranoid type. HALOPERIDOL dosage: unknown. During the same period patient was treated with HALOPERIDOL DECANOATE, HALOPERIDOL DECANOATE, DIAZEPAM. Patient was hospitalized. Patient recovered.
HALOPERIDOL problem was reported by a Health Professional from IRELAND on Nov 14, 2006. Female patient, 68 years of age, was diagnosed with vomiting, nausea and was treated with HALOPERIDOL. After drug was administered, patient experienced the following problems/side effects: bradykinesia, cogwheel rigidity, hypercalcaemia, masked facies, musculoskeletal stiffness, salivary hypersecretion. HALOPERIDOL dosage: unknown. During the same period patient was treated with CYCLIZINE. Patient was hospitalized and became disabled. Patient recovered.
Physician from UNITED STATES reported HALOPERIDOL problem on Nov 13, 2006. Female patient, 51 years of age, was treated with HALOPERIDOL. After drug was administered, patient experienced the following problems/side effects: acute respiratory distress syndrome, blood pressure diastolic decreased, hypertension, ileus paralytic, intentional overdose, lethargy, mental impairment, sinus tachycardia. HALOPERIDOL dosage: unknown. During the same period patient was treated with RISPERDONE, ACETAMINOPHEN, BENZTROPINE MESYLATE. Patient died.
HALOPERIDOL problem was reported by a Physician from UNITED STATES on Nov 13, 2006. Male patient, 20 years of age, was treated with HALOPERIDOL. After drug was administered, patient experienced the following problems/side effects: cardio-respiratory arrest, heart rate increased, refusal of treatment by patient. HALOPERIDOL dosage: unknown. During the same period patient was treated with NORTRIPTYLINE, ACETYLSALICYLIC ACID SRT. Patient died.
Consumer or non-health professional from UNITED STATES reported HALOPERIDOL problem on Mar 02, 2006. Female patient, 57 years of age, weighting 279.9 lb, was treated with HALOPERIDOL. After drug was administered, patient experienced the following problems/side effects: biliary tract disorder, blood cholesterol abnormal, cardiac failure congestive, diabetes mellitus non-insulin-dependent, hypertension, metabolic disorder, myocardial infarction, myocardial ischaemia, pulmonary embolism. HALOPERIDOL dosage: unknown. During the same period patient was treated with CARBAMAZEPINE, SERTRALINE, ACEBUTOLOL, PROPRANOLOL, ESTROGENS CONJUGATED W, ZYPREXA. Patient was hospitalized. Patient recovered.
HALOPERIDOL problem was reported by a Physician from NETHERLANDS on Nov 14, 2006. Male patient, 45 years of age, was diagnosed with schizophrenia, paranoid type and was treated with HALOPERIDOL. After drug was administered, patient experienced the following problems/side effects: anxiety, complicated fracture, contusion, fall, inappropriate antidiuretic hormone secretion, mental disorder, radius fracture, rib fracture, spinal fracture. HALOPERIDOL dosage: 2.5 MG TID UNK. During the same period patient was treated with QUETIAPINE FUMARATE, QUESTIAPINE, MIDAZOLAM HYDROCHLORIDE. Patient recovered.
Consumer or non-health professional from UNITED STATES reported HALOPERIDOL problem on Mar 02, 2006. Male patient, 58 years of age, weighting 467.4 lb, was treated with HALOPERIDOL. After drug was administered, patient experienced the following problems/side effects: blood cholesterol abnormal, blood triglycerides increased, cardiac operation, diabetes mellitus, glycosuria, myocardial ischaemia, vision blurred. HALOPERIDOL dosage: unknown. During the same period patient was treated with ZYPREXA. Patient was hospitalized. Patient recovered.
HALOPERIDOL problem was reported by a Physician from BRAZIL on Dec 08, 2006. Male patient, 24 years of age, weighting 176.4 lb, was treated with HALOPERIDOL. After drug was administered, patient experienced the following problems/side effects: overdose, somnolence, suicide attempt. HALOPERIDOL dosage: unknown. During the same period patient was treated with CARBAMAZEPINE, ETHANOL. Patient recovered.
Pharmacist from UNITED STATES reported HALOPERIDOL problem on Nov 29, 2006. Male patient, 35 years of age, weighting 269.0 lb, was diagnosed with schizophrenia and was treated with HALOPERIDOL. After drug was administered, patient experienced the following problems/side effects: disease recurrence, psychotic disorder. HALOPERIDOL dosage: 5 MG (5 MG/ML), INTRAMUSCULAR. During the same period patient was treated with RISPERIDONE, CLOZAPINE, VALPROATE, FLUOXETINE HYDROCHLORIDE. Patient died on 07/07/2006.
HALOPERIDOL problem was reported by a Pharmacist from FRANCE on Dec 12, 2006. Female patient, 75 years of age, weighting 105.8 lb, was diagnosed with psychotic disorder and was treated with HALOPERIDOL. After drug was administered, patient experienced the following problems/side effects: weight decreased. HALOPERIDOL dosage: unknown. Patient recovered.
Physician from UNITED STATES reported HALOPERIDOL problem on Dec 14, 2006. Female patient, 28 years of age, was diagnosed with schizoaffective disorder and was treated with HALOPERIDOL. After drug was administered, patient experienced the following problems/side effects: pericardial effusion, pericarditis. HALOPERIDOL dosage: unknown. During the same period patient was treated with ZYPREXA, COGENTIN, DEPAKOTE ER, LEVAQUIN, ALBUTEROL, NEXIUM. Patient was hospitalized. Patient recovered.
HALOPERIDOL problem was reported by a Physician from FRANCE on June 07, 2007. Male patient, 53 years of age, was diagnosed with bipolar i disorder and was treated with HALOPERIDOL. After drug was administered, patient experienced the following problems/side effects: pulmonary embolism. HALOPERIDOL dosage: unknown. During the same period patient was treated with NOCTAMIDE, TEGRETOL. Patient was hospitalized. Patient recovered.
Pharmacist from UNITED STATES reported HALOPERIDOL problem on July 06, 2007. Female patient, 82 years of age, was diagnosed with agitation and was treated with HALOPERIDOL. After drug was administered, patient experienced the following problems/side effects: convulsion, dystonia. HALOPERIDOL dosage: 2 MG ONCE IV. During the same period patient was treated with PLAVIX, LEVOTHYROXINE, CALCIUM, NEURONTIN, CELEXA, ASPIRIN, VYTORIN, BUPROPION. Patient recovered.
HALOPERIDOL problem was reported by a Pharmacist from UNITED STATES on July 09, 2007. Male patient was diagnosed with bipolar disorder and was treated with HALOPERIDOL. After drug was administered, patient experienced the following problems/side effects: abnormal behaviour, dysarthria, neuroleptic malignant syndrome. HALOPERIDOL dosage: 5-10MG Q 6 HOURS PRN IV. During the same period patient was treated with LITHIUM CARBONATE. Patient recovered.
Pharmacist from UNITED STATES reported HALOPERIDOL problem on July 11, 2007. Female patient, weighting 115.0 lb, was diagnosed with psychotic disorder and was treated with HALOPERIDOL. After drug was administered, patient experienced the following problems/side effects: neuroleptic malignant syndrome. HALOPERIDOL dosage: 5MG 2 DOSES INJ. Patient was hospitalized. Patient recovered.
HALOPERIDOL problem was reported by a Pharmacist from UNITED STATES on July 16, 2007. Male patient, 50 years of age, was diagnosed with schizophrenia, disorganised type and was treated with HALOPERIDOL. After drug was administered, patient experienced the following problems/side effects: malaise. HALOPERIDOL dosage: 120 MG Q 4 WEEKS IM. Patient died on 07/02/2007.
Pharmacist from UNITED STATES reported HALOPERIDOL problem on July 13, 2007. Male patient, 50 years of age, was diagnosed with schizophrenia and was treated with HALOPERIDOL. HALOPERIDOL dosage: 1200MG/IV (TOTAL FOR BOTH LOTS). During the same period patient was treated with HALOPERIDOL DECANOATE. Patient died on 07/02/2007.
HALOPERIDOL problem was reported by a Pharmacist from UNITED STATES on July 24, 2007. Female patient, 39 years of age, was diagnosed with bipolar disorder and was treated with HALOPERIDOL. After drug was administered, patient experienced the following problems/side effects: extrapyramidal disorder. HALOPERIDOL dosage: 5 MG Q4PRN IM. During the same period patient was treated with TRAZODONE, TEGRETOL. Patient was hospitalized. Patient recovered.
Pharmacist from UNITED STATES reported HALOPERIDOL problem on July 27, 2007. Male patient, 31 years of age, was treated with HALOPERIDOL. After drug was administered, patient experienced the following problems/side effects: dystonia. HALOPERIDOL dosage: 2MG PRN PO. Patient recovered.
HALOPERIDOL problem was reported by a Physician from JAPAN on Aug 06, 2007. Male patient, 59 years of age, was treated with HALOPERIDOL. After drug was administered, patient experienced the following problems/side effects: blood creatine phosphokinase increased. HALOPERIDOL dosage: unknown. Patient was hospitalized. Patient recovered.
Health Professional from UNITED STATES reported HALOPERIDOL problem on Aug 14, 2007. Male patient, weighting 116.0 lb, was diagnosed with schizophrenia, antiviral prophylaxis, hiv infection and was treated with HALOPERIDOL. After drug was administered, patient experienced the following problems/side effects: blood creatinine increased. HALOPERIDOL dosage: unknown. During the same period patient was treated with HALDOL, TRUVADA, NORVIR, REYATAZ, COGENTIN. Patient recovered.
HALOPERIDOL problem was reported by a Physician from FRANCE on Aug 22, 2007. Female patient, 42 years of age, was diagnosed with schizophrenia and was treated with HALOPERIDOL. After drug was administered, patient experienced the following problems/side effects: trismus. HALOPERIDOL dosage: unknown. Patient recovered.
Physician from CROATIA (local name: Hrvatska) reported HALOPERIDOL problem on Aug 16, 2007. Male patient, 44 years of age, was diagnosed with psychotic disorder, anxiety, depression, hallucination, insomnia, schizophrenia and was treated with HALOPERIDOL. After drug was administered, patient experienced the following problems/side effects: cardiac arrest, hyperglycaemia, inappropriate antidiuretic hormone secretion, pancreatitis haemorrhagic. HALOPERIDOL dosage: 12 MG, DAILY, ORAL. During the same period patient was treated with DIAZEPAM, ALPRAZOLAM, PAROXETINE HYDROCHLORIDE, FLUPHENAZINE DECANOATE. Patient died.
HALOPERIDOL problem was reported by a Health Professional from ITALY on Aug 23, 2007. Female patient, 85 years of age, was diagnosed with psychomotor hyperactivity, diabetic neuropathy, abdominal pain upper and was treated with HALOPERIDOL. After drug was administered, patient experienced the following problems/side effects: abdominal pain upper, psychomotor hyperactivity, pulmonary congestion, renal failure acute, respiratory failure, rhabdomyolysis, somnolence. HALOPERIDOL dosage: 10 MG. During the same period patient was treated with GABAPENTIN, LANSOPRAZOLE, INSULIN LISPRO, RAMIPRIL, ASPIRIN, DILTIAZEM. Patient recovered.
Pharmacist from UNITED STATES reported HALOPERIDOL problem on Sept 13, 2007. Female patient, weighting 150.3 lb, was treated with HALOPERIDOL. After drug was administered, patient experienced the following problems/side effects: tachypnoea, wheezing. HALOPERIDOL dosage: unknown. Patient recovered.
HALOPERIDOL problem was reported by a Pharmacist from UNITED STATES on Sept 24, 2007. Female patient, 24 years of age, weighting 125.0 lb, was diagnosed with mania, paranoia and was treated with HALOPERIDOL. After drug was administered, patient experienced the following problems/side effects: cogwheel rigidity, extrapyramidal disorder, eye rolling. HALOPERIDOL dosage: 7.5 MG PO. Patient recovered.
Pharmacist from UNITED STATES reported HALOPERIDOL problem on Sept 24, 2007. Female patient, 25 years of age, weighting 137.0 lb, was treated with HALOPERIDOL. After drug was administered, patient experienced the following problems/side effects: mental status changes, muscle rigidity, nuchal rigidity, oculogyric crisis, restlessness. HALOPERIDOL dosage: 5MG PRN PO 2 DOSES. Patient recovered.
HALOPERIDOL problem was reported by a Pharmacist from UNITED STATES on Sept 24, 2007. Male patient, 24 years of age, weighting 166.0 lb, was treated with HALOPERIDOL. After drug was administered, patient experienced the following problems/side effects: blepharospasm, musculoskeletal stiffness, parkinsonism, vision blurred. HALOPERIDOL dosage: 5 MG PO. Patient recovered.
Pharmacist from UNITED STATES reported HALOPERIDOL problem on Sept 25, 2007. Male patient, weighting 200.0 lb, was diagnosed with schizophrenia, depression and was treated with HALOPERIDOL. After drug was administered, patient experienced the following problems/side effects: akathisia, dystonia, extrapyramidal disorder, facial palsy, mental disorder, musculoskeletal stiffness, speech disorder, tongue disorder. HALOPERIDOL dosage: 5MG BID PO. During the same period patient was treated with PAROXETINE. Patient recovered.
HALOPERIDOL problem was reported by a Physician from UNITED STATES on Sept 11, 2007. Male patient, 26 years of age, was diagnosed with bipolar disorder and was treated with HALOPERIDOL. After drug was administered, patient experienced the following problems/side effects: dysarthria, dystonia, headache, joint dislocation, mastication disorder, weight decreased. HALOPERIDOL dosage: unknown. Patient recovered.
Physician from UNITED STATES reported HALOPERIDOL problem on Sept 11, 2007. Male patient, 26 years of age, was diagnosed with bipolar disorder and was treated with HALOPERIDOL. After drug was administered, patient experienced the following problems/side effects: bipolar disorder, dystonia, headache, joint dislocation, weight decreased. HALOPERIDOL dosage: unknown. During the same period patient was treated with QUETIAPINE FUMARATE, MOOD STABILIZER. Patient recovered.
Showing 1-75 of 122 Next >